The fact
The stock is discussed on social media for its resilience against market 'jackals'.
Investors are watching the biotech's upcoming clinical results.
Click the link to read an article on the topic:
The stock is discussed on social media for its resilience against market 'jackals'.
Investors are watching the biotech's upcoming clinical results.